EFFECTS OF DRUGS AND DISEASES ON CHOLINESTERASE ACTIVITY
Main researcher
: KUNEC-VAJIĆ, ESTERA (24653) Assistants
BRADAMANTE, VLASTA (5110)
POPOVIĆ, LJILJANA (113536)
Type of research: basic Duration from: 01/01/91. to 12/15/95. Papers on project (total): 19
Papers on project quoted in Current Contents: 2
Institution name: Medicinski fakultet, Zagreb (108) Department/Institute: Department of pharmacology Address: Šalata 11, pp 916 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (0)1 4566-927
Fax: 385 (0)1 424-001
Summary: The role of ChE in the metabolism of lipids and
lipoproteins has been investigated. ChE activity in plasma, liver and
adipose tissue has been determined in rats with pathologically disturbed
lipid metabolism (diabetes, fasting, hyper- and hypothyreosis) as well as
after the administration of drugs which influence plasma levels of lipids
and lipoproteins (hypolipidemic agents, acetylsalicylic acid,
beta-blockers, estrogens, progesterone). Plasma ChE activities in patients
with hyper- and hypothyreosis were also measured. According to our results
liver ChE activity correlates better with the level of VLDL production than
with the level of peroxisomal beta-oxidation. The alterations of adipose
tissue ChE activity were independent of the alterations of liver ChE
activity. Moreover, as ChE activity in liver and adipose tissue were
differently affected by age and sex, it has been proposed that adipose
tissue ChE did not originate from the liver. It seems that adipose tissue
ChE is also involved in lipid metabolism since it has been noticed that
adipose tissue ChE activity is always increased in the states with enhanced
triglyceride deposition in adipose tissue.
Research goals: The primary aim of our studies was to gain further
informations concerning the physiological role of ChE in the body. The
determination of ChE activity in states with disturbed lipid and
lipoprotein metabolism could shed light on the involvement of ChE in the
metabolism of lipids and lipoproteins. Investigating the effects of drugs
on ChE activity (various hypolipidemic agents, acetylsalicylic acid,
oxprenolol, levothyroxin, propylthiouracil, estradiol, progesterone)
additional data on the mechanism of action or side effects of these drugs
could be obtained. Other information about the project.